ABBV vs LPCN · P/E 81, rev $16.99B vs rev $309.5K
AbbVie Inc (ABBV) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the ABBV and LPCN stock pages for the full models.
Not investment advice.